Bobby Milstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bobby Milstein has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jack Homer
Homer Consulting and MIT Research Affiliate, Barrytown, NY 12507, USA
2 shared publications Andrew Jones
1 shared publicationDara Murphy
1 shared publicationDeron Burton
Deron Burton is a Commissioned Corps officer at the Center for Global Health, at the Centers for Disease Control and Prevention
1 shared publicationDon Seville
1 shared publication- Gary B. Hirsch
Creator of Learning Environments
1 shared publication
Latest Publications
- 1 May 2011
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 30 (5) , 823-832
Why Behavioral And Environmental Interventions Are Needed To Improve Health At Lower Cost
We used a dynamic simulation model of the US health system to test three proposed strategies to reduce deaths and improve the cost-effectiveness of interventions: expanding health insurance coverage, delivering better preventive and chronic care, and protecting health by enabling healthier behavior and improving environmental conditions. We found that each alone could save lives and provide good economic value, but they are likely to be more effective in combination. Although coverage and care save lives quickly, they tend to increase costs. The impact of protection grows more gradually, but it is a critical ingredient over time for lowering both the number of deaths and reducing costs. Only protection slows the growth in the prevalence of disease and injury and thereby alleviates rather than exacerbates demand on limited primary care capacity. When added to a simulated scenario with coverage and care, protection could save 90 percent more lives and reduce costs by 30 percent in year 10; by year 25, that same investment in protection could save about 140 percent more lives and reduce costs by 62 percent.
- 1 May 2011
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 30 (5) , 823-832
Why Behavioral And Environmental Interventions Are Needed To Improve Health At Lower Cost
We used a dynamic simulation model of the US health system to test three proposed strategies to reduce deaths and improve the cost-effectiveness of interventions: expanding health insurance coverage, delivering better preventive and chronic care, and protecting health by enabling healthier behavior and improving environmental conditions. We found that each alone could save lives and provide good economic value, but they are likely to be more effective in combination. Although coverage and care save lives quickly, they tend to increase costs. The impact of protection grows more gradually, but it is a critical ingredient over time for lowering both the number of deaths and reducing costs. Only protection slows the growth in the prevalence of disease and injury and thereby alleviates rather than exacerbates demand on limited primary care capacity. When added to a simulated scenario with coverage and care, protection could save 90 percent more lives and reduce costs by 30 percent in year 10; by year 25, that same investment in protection could save about 140 percent more lives and reduce costs by 62 percent.
- 15 June 2007
- Vol. 4 (3) , A52
Charting Plausible Futures for Diabetes Prevalence in the United States: A Role for System Dynamics Simulation Modeling
Healthy People 2010 (HP 2010) objectives call for a 38% reduction in the prevalence of diagnosed diabetes mellitus, type 1 and type 2, by the year 2010. The process for setting this objective, however, did not focus on the achievability or the compatibility of this objective with other national public health objectives. We used a dynamic simulation model to explore plausible trajectories for diabetes prevalence in the wake of rising levels of obesity in the U.S. population. The model helps to interpret historic trends in diabetes prevalence in the United States and to anticipate plausible future trends through 2010. We conducted simulation experiments using a computer model of diabetes population dynamics to 1) track the rates at which people develop diabetes, are diagnosed with the disease, and die, and 2) assess the effects of various preventive-care interventions. System dynamics modeling methodology based on data from multiple sources guided the analyses. With the number of new cases of diabetes being much greater than the number of deaths among those with the disease, the prevalence of diagnosed diabetes in the United States is likely to continue to increase. Even a 29% reduction in the number of new cases (the HP 2010 objective) would only slow the growth, not reverse it. Increased diabetes detection rates or decreased mortality rates — also HP 2010 objectives — would further increase diagnosed prevalence. The HP 2010 objective for reducing diabetes prevalence is unattainable given the historical processes that are affecting incidence, diagnosis, and mortality, and even a zero-growth future is unlikely. System dynamics modeling shows why interventions to protect against chronic diseases have only gradual effects on their diagnosed prevalence.
- 15 June 2007
- Vol. 4 (3) , A52
Charting Plausible Futures for Diabetes Prevalence in the United States: A Role for System Dynamics Simulation Modeling
Healthy People 2010 (HP 2010) objectives call for a 38% reduction in the prevalence of diagnosed diabetes mellitus, type 1 and type 2, by the year 2010. The process for setting this objective, however, did not focus on the achievability or the compatibility of this objective with other national public health objectives. We used a dynamic simulation model to explore plausible trajectories for diabetes prevalence in the wake of rising levels of obesity in the U.S. population. The model helps to interpret historic trends in diabetes prevalence in the United States and to anticipate plausible future trends through 2010. We conducted simulation experiments using a computer model of diabetes population dynamics to 1) track the rates at which people develop diabetes, are diagnosed with the disease, and die, and 2) assess the effects of various preventive-care interventions. System dynamics modeling methodology based on data from multiple sources guided the analyses. With the number of new cases of diabetes being much greater than the number of deaths among those with the disease, the prevalence of diagnosed diabetes in the United States is likely to continue to increase. Even a 29% reduction in the number of new cases (the HP 2010 objective) would only slow the growth, not reverse it. Increased diabetes detection rates or decreased mortality rates — also HP 2010 objectives — would further increase diagnosed prevalence. The HP 2010 objective for reducing diabetes prevalence is unattainable given the historical processes that are affecting incidence, diagnosis, and mortality, and even a zero-growth future is unlikely. System dynamics modeling shows why interventions to protect against chronic diseases have only gradual effects on their diagnosed prevalence.
- Open Access
- 1 June 2007
- Published by Wiley in System Dynamics Review
- Vol. 23 (2-3) , 313-343
Chronic illness in a complex health economy: the perils and promises of downstream and upstream reforms
Chronic illness is the largest cause of death and source of health care costs in developed countries and a growing problem in developing countries. Here we build on past work in system dynamics and present a generic model of chronic illness, its treatment and prevention, applied to the U.S. population. The model explains the rising prevalence of illness and responses to it, including the treatment of complications and management activities designed to reduce complications. We show how progress in treatment and disease management has slowed since 1980 in the U.S., largely due to competition between health care payers and providers, resulting in price inflation and an unstable climate for health care investments. We demonstrate the impact of moving “upstream” by managing known risk factors to prevent illness onset, and moving even further upstream by addressing behaviors and living conditions linked to the initial development of these risk factors. Copyright © 2007 John Wiley & Sons, Ltd.
- 1 June 2007
- Published by Wiley in System Dynamics Review
- Vol. 23 (2-3) , 313-343
Open AccessChronic illness in a complex health economy: the perils and promises of downstream and upstream reforms
Chronic illness is the largest cause of death and source of health care costs in developed countries and a growing problem in developing countries. Here we build on past work in system dynamics and present a generic model of chronic illness, its treatment and prevention, applied to the U.S. population. The model explains the rising prevalence of illness and responses to it, including the treatment of complications and management activities designed to reduce complications. We show how progress in treatment and disease management has slowed since 1980 in the U.S., largely due to competition between health care payers and providers, resulting in price inflation and an unstable climate for health care investments. We demonstrate the impact of moving “upstream” by managing known risk factors to prevent illness onset, and moving even further upstream by addressing behaviors and living conditions linked to the initial development of these risk factors. Copyright © 2007 John Wiley & Sons, Ltd.
- 1 March 2006
- Published by American Public Health Association in American Journal of Public Health
- Vol. 96 (3) , 403-405
Systems Thinking and Modeling for Public Health Practice
- 1 March 2006
- Published by American Public Health Association in American Journal of Public Health
- Vol. 96 (3) , 403-405
Systems Thinking and Modeling for Public Health Practice